Tenaya Therapeutics is trading 5.4% down at $0.66 versus its August 21, 2026 close of $0.70, with no clear company-specific catalyst identified.
- No clearly reported company-specific announcement, earnings update, regulatory action, or analyst change was found for August 24, 2026.
- Latest developments: its August 5 quarterly report and August 11 investor conference, with fourth-quarter pipeline updates discussed.
- Broader market was modestly mixed: S&P 500 down 0.17% and Nasdaq Composite down 0.34%; trading activity details were unavailable.